Jim Tananbaum is a prominent figure in the healthcare and biotechnology sectors, known for his significant contributions as an investor, entrepreneur, and healthcare visionary. He is the founder and CEO of Foresite Capital, a venture capital firm focused on funding transformative healthcare innovations. He has been actively involved in biomarker investments, supporting companies that develop innovative biomarker-based solutions to improve disease detection and treatment. He has invested in Juno Therapeutics, 10x Genomics and Intarcia Therapeutics.